Clinical trial
GLP-1 Agonists as Neoadjuvant Therapy for Surgical Treatment of Type 2 Diabetes: A Randomized Controlled Trial
NCT04624672 is registered in ClinicalTrials.gov with Geisinger Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GLP-1 Agonists as Neoadjuvant Therapy for Surgical Treatment of Type 2 Diabetes: A Randomized Controlled Trial
- Lead sponsor
- Geisinger Clinic
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- August 25, 2021
- Completion date
- August 17, 2022
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.